With multiple regulators expected to mandate postmarketing studies, standard requirements would be beneficial, Tito Roccia said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
